Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Coustan-Smith

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Leukemia|July 1, 1994
Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemiaM Kumagai, A Manabe, E Coustan-Smith, et al.
Blood|May 15, 1997
Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemiaH Nishigaki, C Ito, A Manabe, et al.
Blood|February 15, 1993
Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 proteinD Campana, E Coustan-Smith, A Manabe, et al.
Bone Marrow Transplantation|May 1, 1994
XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donorsM Koehler, C A Hurwitz, R A Krance, et al.
The New England Journal of Medicine|November 14, 1996
Mutations in the mu heavy-chain gene in patients with agammaglobulinemiaL Yel, Y Minegishi, E Coustan-Smith, et al.
The Journal of Clinical Investigation|October 1, 1994
Hyper IgM syndrome associated with defective CD40-mediated B cell activationM E Conley, M Larché, V R Bonagura, et al.
Cell Death and Differentiation|February 1, 1997
Fas activates NF-kappaB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-alphaG Packham, J M Lahti, B E Fee, et al.
Blood|December 24, 1998
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosisC Ito, M Kumagai, A Manabe, et al.
Leukemia|February 25, 2005
Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central AmericaS C Howard, D Campana, E Coustan-Smith, et al.
Human Gene Therapy|July 3, 1998
Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastomaL C Bowman, M Grossmann, D Rill, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Leukemia|July 1, 1994
Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemiaM Kumagai, A Manabe, E Coustan-Smith, et al.
Blood|May 15, 1997
Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemiaH Nishigaki, C Ito, A Manabe, et al.
Blood|February 15, 1993
Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 proteinD Campana, E Coustan-Smith, A Manabe, et al.
Bone Marrow Transplantation|May 1, 1994
XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donorsM Koehler, C A Hurwitz, R A Krance, et al.
The New England Journal of Medicine|November 14, 1996
Mutations in the mu heavy-chain gene in patients with agammaglobulinemiaL Yel, Y Minegishi, E Coustan-Smith, et al.
The Journal of Clinical Investigation|October 1, 1994
Hyper IgM syndrome associated with defective CD40-mediated B cell activationM E Conley, M Larché, V R Bonagura, et al.
Cell Death and Differentiation|February 1, 1997
Fas activates NF-kappaB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-alphaG Packham, J M Lahti, B E Fee, et al.
Blood|December 24, 1998
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosisC Ito, M Kumagai, A Manabe, et al.
Leukemia|February 25, 2005
Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central AmericaS C Howard, D Campana, E Coustan-Smith, et al.
Human Gene Therapy|July 3, 1998
Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastomaL C Bowman, M Grossmann, D Rill, et al.
Pageof 7